Press Releases

Westbury, NY - August 10, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has acquired Asterand Bioscience™, a global provider of high quality, well-characterized human tissue and research solutions with a focus on the oncology market. Asterand Bioscience advances drug research by accelerating target identification and biomarker validation, and improving drug candidate selection to increase the likelihood of clinical success. “We are delighted that Asterand Bioscience’s talented staff is joining BioreclamationIVT. This is a great fit between two complementary...

Press Releases

WESTBURY, N.Y. - July 31, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has expanded its infectious disease-state portfolio to include frozen whole blood, plasma and serum samples from patients with HIV-1, HIV-2, dengue, zika and malaria infection. The HIV-1 collection includes samples from pediatric patients and pregnant women. “We are pleased to be able to provide biopharmaceutical companies with these vitally important biological samples that their researchers need to create diagnostics and develop therapeutic drugs and vaccines against these dreadful...

Press Releases

Westbury, NY - July 26, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has appointed Karen Sasse to the newly-created position of vice president of global quality and compliance. Ms. Sasse will be responsible for the company’s quality assurance and quality control activities worldwide.   “We are delighted to have an operations professional of Karen’s caliber join our growing team. Her drive, strong project management skills, and superlative attention to detail will help to ensure that our biological products continue to exceed our customers’ highest...

Press Releases

WESTBURY, N.Y. - June 22, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it is partnering with Qualyst Transporter Solutions, LLC (Qualyst) to market Transporter Certified™ cryopreserved human hepatocytes. Transporter Certified is an industry standard that ensures hepatocytes have physiologic transporter function, metabolic competence and appropriate regulatory pathways under conditions Qualyst has defined. In sandwich culture, the intracellular concentrations in Transporter Certified hepatocytes reflect physiologic conditions because the hepatocytes express...

Press Releases

WESTBURY, N.Y. - April 13, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, has signed a new distribution partnership agreement with Cellaria, LLC. According to the terms of the agreement, BioreclamationIVT will have exclusive market and distribution rights to Cellaria's novel cancer cell lines and cancer culture media in the United States and Canada and non-exclusive rights to sell the products globally. The agreement expands the availability of Cellaria's offerings to a broader range of potential customers via an established distribution partner with existing relationships inside the...

Press Releases

Pages